Aspen Pharmacare Holdings Limited's latest marketcap:
As of 07/04/2025, Aspen Pharmacare Holdings Limited's market capitalization has reached $3.06 B. According to our data, Aspen Pharmacare Holdings Limited is the 4736th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.06 B |
| Revenue (ttm) | 2.56 B |
| Net Income (ttm) | 252.11 M |
| Shares Out | 444.21 M |
| EPS (ttm) | 0.57 |
| Forward PE | 10.57 |
| Ex-Dividend Date | 09/18/2024 |
| Earnings Date | 09/03/2025 |
Aspen Pharmacare Holdings Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/04/2025 | R3.06 B | -27.21% | 4736 |
| 12/31/2024 | R73.23 B | -19.13% | 3633 |
| 12/29/2023 | R90.55 B | 49.27% | 2890 |
| 12/30/2022 | R60.66 B | -40.62% | 3552 |
| 12/31/2021 | R102.16 B | 78.88% | 2626 |
| 12/31/2020 | R57.11 B | 5.09% | 3465 |
| 12/31/2019 | R54.34 B | -11.6% | 2898 |
| 12/31/2018 | R61.47 B | -51.42% | 2330 |
| 12/29/2017 | R126.55 B | -2.12% | 1274 |
| 12/30/2016 | R129.29 B | -8.39% | 1077 |
Company Profile
About Aspen Pharmacare Holdings Limited
Aspen Pharmacare Holdings Limited, together with its subsidiaries, is a global manufacturer and supplier of specialty and branded pharmaceutical products. Headquartered in Durban, South Africa, the company was founded in 1850 and operates across two primary segments:
- Commercial Pharmaceuticals
- Manufacturing
Key Product Offerings
Aspen Pharmacare provides a diverse range of pharmaceutical solutions, including:
- Anesthetics: Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine.
- Therapeutic Solutions: Circadin (sleeping aid), Eltroxin (thyroid hormone), Foxair, Imuran (immunosuppressant), Maltofer (iron supplement), Mybulen (analgesic anti-inflammatory), and Ovestin (hormone replacement therapy).
Additional Operations
The company also engages in the manufacturing and sale of:
- Active pharmaceutical ingredients (APIs).
- Finished dose form products.
Frequently Asked Questions
-
What is Aspen Pharmacare Holdings Limited's (JSE-APN) current market cap?As of 07/04/2025, Aspen Pharmacare Holdings Limited (including the parent company, if applicable) has an estimated market capitalization of $3.06 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Aspen Pharmacare Holdings Limited (JSE-APN) rank globally by market cap?Aspen Pharmacare Holdings Limited global market capitalization ranking is approximately 4736 as of 07/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.